Black Swift Group’s iShares Biotechnology ETF IBB Stock Holding History

Black Swift Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-32,850	Closed	-$3.58M	–	66
2019 Q2	$3.58M	Buy	32,850 +31,350	+2,090%	+$3.33M	4.7%	5
2019 Q1	$168K	Buy	+1,500	New	+$165K	0.24%	35
2018 Q3	–	Sell	-4,150	Closed	-$456K	–	92
2018 Q2	$456K	Sell	4,150 -150	-3%	-$16K	0.21%	18
2018 Q1	$459K	Sell	4,300 -500	-10%	-$55.4K	0.33%	20
2017 Q4	$512K	Buy	+4,800	New	+$513K	0.48%	18
2017 Q3	–	Sell	-80,595	Closed	-$8.33M	–	42
2017 Q2	$8.33M	Buy	+80,595	New	+$7.94M	4.53%	5

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Black Swift Group's IBB Position: Q3 2019 in Review

Black Swift Group sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 32,850 shares — an estimated $3.58M sold.

Black Swift Group first reported a position in IBB in Q2 2017 and held it in 6 quarters. The position peaked at $8.33M in Q2 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Black Swift Group reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Black Swift Group sold 32,850 iShares Biotechnology ETF shares in Q3 2019, an estimated $3.58M.
Black Swift Group first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 6 quarters.
Black Swift Group's iShares Biotechnology ETF position peaked at $8.33M in Q2 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Black Swift Group's 13F filing for Q3 2019, filed 9 Feb 2021.